Research News and Research

RSS

Chemical components of elderberry, cinnamon and green tea extracts block HIV viruses from infecting cells

The development of new antiviral drugs has had a tremendous impact on the quality of life and life expectancy of HIV-positive and AIDS patients, as the drugs effectively disrupt the replication cycle of the HIV virus. Yet the regular use of those drugs - such as zidovudine (also known as azidothymidine or AZT), protease inhibitors, and highly active antiretroviral therapy (HAART) involving multidrug therapies - has led to resistant HIV strains.

20 Aug 2009

Software suite for comprehensive analysis of cardiac safety released by NewCardio

NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic technology provider, today announced that the Company has formally launched its lead product, QTinno(TM), a software suite that provides an automated, comprehensive analysis of cardiac safety for the pharmaceutical industry.

20 Aug 2009

IBISS research group's project aims to examine Ribavirin role in promoting the survival of transplanted stem cells

Hard to Treat Diseases (HTDS.PK) Dr. Sanja Pekovic, Chief Project Scientist, Chief Strategy Officer Slavica BioChem reported that IBISS research group from Serbia has begun preliminary experiments within a project aimed at Promoting stem cell graft survival in the model of traumatic brain injury in rats.

20 Aug 2009

SCS becomes the first IT systems integration services provider to join Medidata’s ASPire to Win program

Medidata Solutions, a leading global provider of hosted clinical development solutions, today announced that Sumisho Computer Systems Corporation (SCS) has become the first IT systems integration services provider to join Medidata’s ASPire to Win® program for contract research organizations (CROs) and service providers.

20 Aug 2009

Varian Medical Systems to equip a new proton therapy center in Sweden

Varian Medical Systems today announced it has been selected to equip a new proton therapy center in Sweden. In a ceremony conducted by Swedish authorities yesterday following a public tender, Varian was named to supply an estimated $60 million in products for Skandionkliniken, a new national proton therapy center owned by a consortium of seven of Sweden's counties.

20 Aug 2009

Medical students give a poor grade to the U.S. healthcare system according to Epocrates' survey

Medical students give the U.S. healthcare system a poor grade and consider technology a ‘must have’ for their future practice. These opinions and technology priorities, including mobile reference and electronic medical records (EMRs), are represented in the fourth annual Future Physicians of America survey by Epocrates, Inc., the leading provider of mobile medical technology.

20 Aug 2009

Helicos Genetic Analysis System to aid Ontario Institute for Cancer Research scientists in the study of cancer genomics

Helicos BioSciences Corporation (NASDAQ: HLCS), a life science company focused on innovative genetic analysis technologies, today announced the placement of a Helicos™ Genetic Analysis System at the Ontario Institute for Cancer Research (OICR) with Drs. Tom Hudson and John McPherson.

20 Aug 2009

Shape-changing in proteins opens new avenue for drug discovery

Computational biologists at the University of Pittsburgh School of Medicine have shown that proteins have an intrinsic ability to change shape, and this is required for their biological activity. This shape-changing also allows the small molecules that are attracted to a given protein to select the structure that permits the best binding. That premise could help in drug discovery and in designing compounds that will have the most impact on protein function to better treat a host of diseases.

20 Aug 2009

Squabbling Democrats prepare to move ahead on health bills without GOP

The New York Times: "Democrats now say they see little chance of the minority's cooperation in approving any overhaul, and are increasingly focused on drawing support for a final plan from within their own ranks. Top Democrats said Tuesday that their go-it-alone view was being shaped by what they saw as Republicans' purposely strident tone against health care legislation during this month's Congressional recess, as well as remarks by leading Republicans that current proposals were flawed beyond repair."

20 Aug 2009

Fluxion Biosciences receives a $1.8 million NIH grant for developing microfluidic platform

Fluxion Biosciences, a leading developer of microfluidic systems for functional cell analysis, today announced that it has received a $1.8 million NIH grant for the development of a high-throughput screening platform for anti-microbial drug discovery.

From Fluxion Biosciences 20 Aug 2009

Some HIV-positive Ugandans' not receiving antiretrovirals

Some HIV-positive people in Uganda "cannot be put on the national antiretroviral [ARV] programme because it is already saturated and funds for new patients are not available," the Independent reports. According to the newspaper, roughly 360,000 HIV-positive Ugandans are eligible for antiretroviral treatment because their CD4 counts are below the WHO's threshold of 350; however, about half of them currently do not have access to ARVs.

20 Aug 2009

State round-up: New Jersey hospitals, Utah's Medicaid troubles, and more

Wednesday's state news includes a hospital demonstration in New Jersey, Medicaid fraud in Utah, an abortion ruling in Oklahoma, and a White House decision to maintain Wisconsin's unique drug program for seniors.

20 Aug 2009

Does fetal fibronectin testing change patient management in women at risk of preterm labour?

Hologic, Inc. has announced the publication of the first of its kind study evaluating the impact of fetal fibronectin (fFN) testing among both symptomatic and asymptomatic pregnant women at risk for preterm birth. The study, "Does fetal fibronectin testing change patient management in women at risk of preterm labour?" by researchers at King's College, London, England appears in the on-line version of the European Journal of Obstetrics & Gynecology and Reproductive Biology.

20 Aug 2009

Kensey Nash announces financial results for fourth-quarter and full fiscal year 2009

Kensey Nash Corporation (Nasdaq: KNSY), a leading medical technology company that provides innovative solutions and technologies for a wide range of medical procedures, today reported the results for its fourth quarter and fiscal year ended June 30, 2009.

20 Aug 2009

RBC Life Sciences reports on patent-pending, nutritional supplement

RBC Life Sciences, Inc., a provider of proprietary nutritional supplements and wound care/pain management products, announced today the debut of NeuroBright(TM), a patent-pending, nutritional supplement that improved test subjects' learning and memory skills by 50 percent during a recent laboratory trial.

20 Aug 2009

USPTO grants MultiCell Technologies patent for its Fa2N-4 and Ea1C-35 immortalized human hepatocyte cell lines

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) announced today it has been granted U.S. patent 7,566,567 by the United States of America Patent and Trademark Office covering its Fa2N-4 and Ea1C-35 immortalized human hepatocyte cell lines.

20 Aug 2009

Mesenchymal stem cells repair human brain

There is no known cure for neurodegenerative diseases such as Huntington's, Alzheimer's and Parkinson's. But new hope, in the form of stem cells created from the patient's own bone marrow, can be found ― and literally seen ― in laboratories at Tel Aviv University.

20 Aug 2009

Zila starts proxy vote on proposed merger with TOLMAR Holding

Zila, Inc. announced that Proxy Statements and Proxies have been mailed to its stockholders in order to allow them to vote on the proposed merger with a subsidiary of TOLMAR Holding, Inc. Under the terms of the merger agreement, if approved by the stockholders, each Zila stockholder would be entitled to receive $0.45 per share in cash. Tolmar is a privately held, pharmaceutical research, development, manufacturing and commercial operations company.

20 Aug 2009

The Dilemma of an Aging Society research study classifies elder people into four groups

A lot of discussion has centered on proposed legislation regarding "death panels" and end of life counseling.

20 Aug 2009

Consumer-friendly "finger stick" blood test to detect cardiovascular disease is broadly available now

A new blood test, measuring the level of omega-3 fatty acids in red blood cells, is now broadly available for the first time to the public everywhere as a consumer-friendly, at-home "finger stick" test. While scientists have long known of the benefits of fish and fish oil for overall heart health, over the past decade research has proven that the omega-3 fatty acids found in fish dramatically reduce one's risk for cardiovascular disease. Further, recent research indicates that omega-3 levels may be among the best predictors of future coronary heart disease - providing much stronger correlations to the risk of sudden cardiac death than traditional indicators, including HDL and LDL cholesterol.

20 Aug 2009

Research News and Research

Chemical components of elderberry, cinnamon and green tea extracts block HIV viruses from infecting cells

Software suite for comprehensive analysis of cardiac safety released by NewCardio

IBISS research group's project aims to examine Ribavirin role in promoting the survival of transplanted stem cells

SCS becomes the first IT systems integration services provider to join Medidata’s ASPire to Win program

Varian Medical Systems to equip a new proton therapy center in Sweden

Medical students give a poor grade to the U.S. healthcare system according to Epocrates' survey

Helicos Genetic Analysis System to aid Ontario Institute for Cancer Research scientists in the study of cancer genomics

Shape-changing in proteins opens new avenue for drug discovery

Squabbling Democrats prepare to move ahead on health bills without GOP

Fluxion Biosciences receives a $1.8 million NIH grant for developing microfluidic platform

Some HIV-positive Ugandans' not receiving antiretrovirals

State round-up: New Jersey hospitals, Utah's Medicaid troubles, and more

Does fetal fibronectin testing change patient management in women at risk of preterm labour?

Kensey Nash announces financial results for fourth-quarter and full fiscal year 2009

RBC Life Sciences reports on patent-pending, nutritional supplement

USPTO grants MultiCell Technologies patent for its Fa2N-4 and Ea1C-35 immortalized human hepatocyte cell lines

Mesenchymal stem cells repair human brain

Zila starts proxy vote on proposed merger with TOLMAR Holding

The Dilemma of an Aging Society research study classifies elder people into four groups

Consumer-friendly "finger stick" blood test to detect cardiovascular disease is broadly available now

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics